MTS

AI Will Build Totally New Drugs by 2031 | Sam Rodriques

14:41

Edison Scientific founder and CEO Sam Rodriques breaks down their new partnership with Pfizer to deploy superintelligence across pharma R&D. He details how their AI scientists Robin and Cosmos are already discovering novel disease treatments, and maps out why drug repurposing will deliver rapid medical breakthroughs before entirely new AI-designed compounds arrive. Check out our sponsor Lovable:…